These hub genes were associated with progression of obesity associated type 2 diabetes mellitus and first five (CEBPD, TP73, ESR2, TAB1 and MAP 3K5) of them might be linked with targeted therapy. The gene discussed is CEBPD; the disease is diabetes mellitus.